When was Biocare Medical founded?

Biocare Medical was founded in 1997 and raised its 1st funding round 20 years after it was founded.

Where is Biocare Medical located?

Biocare Medical is headquartered in Concord, United States. It is registered at Pacheco, California.

Who is the current CEO of Biocare Medical?

Roy Paxton Yih of Biocare Medical.

How many employees does Biocare Medical have?

As of Jul 31, 2026, the latest employee count at Biocare Medical is 293.

Is Biocare Medical a funded company?

Biocare Medical is a funded company, having raised a total of $85M across 2 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Aug 25, 2017.

When was the latest funding round of Biocare Medical?

Biocare Medical's latest funding was a $***** PE round on Dec 09, 2021, with participation from 1 investor.

Where does Biocare Medical rank among its competitors?

Biocare Medical ranks 4th amongst 308 active competitors, of which 39 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Abselion, which secured $8.41M in Oct, 2024.

Who are the top competitors of Biocare Medical?

Biocare Medical's top competitors include Illumina, Quanterix and BioLife Solutions. Among them, Abselion secured the most recent funding round in October, 2024.

Biocare Medical - 2026 Company Profile, Team, Funding & Competitors

Q: Is Biocare Medical an acquired company?

Biocare Medical got acquired by Agilent on Mar 09, 2026.

Biocare Medical is an acquired company based in Concord (United States), founded in 1997 by Roy Paxton Yih. It operates as a Manufacturer of primary antibodies and instruments for immunohistochemistry applications. Biocare Medical has raised $85M in funding from Excellere Partners. The company has 308 active competitors, including 39 funded and 49 that have exited. Its top competitors include companies like Illumina, Quanterix and BioLife Solutions.

Company Details

Manufacturer of primary antibodies and instruments for immunohistochemistry applications. It offers a wide range of antibodies targeting various proteins, including CD antigens, cytokeratins, and others. These antibodies are used in various research and diagnostic settings to detect specific proteins and markers. It aids in disease diagnosis and research, particularly in the fields of oncology, immunology, and pathology.

Website: biocare.net
Social
Email ID: *****@biocare.net
Phone Number: +1 **********
Registered Address: Pacheco, California

Key Metrics

Founded Year

1997

Location

Concord, United States

Stage

Acquired

Total Funding

$85M in 2 rounds

Latest Funding Round

PE, Dec 09, 2021, $*****

Investors

Excellere Partners & 4 more

Ranked

4^th among 308 active competitors

Employee Count

293 as on Jul 31, 2026

Investment & Acquisitions

Empire Genomics & 1 more

Similar Companies

Illumina & 355 more

Exit Details

Acquired by Agilent (Mar 09, 2026)

View Biocare Medical's full profile

Biocare Medical is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Biocare Medical Llc CIN: 001t000000Wo2KwAAJ , United States, Active	Apr 22, 2016	-	-	-
BIOCARE Solution a.s. CIN: 17772851 , Czech Republic, Active	Nov 24, 2022	-	-
BIOCARE HEALTH LTD CIN: 12076619 , United Kingdom, Active	Jun 30, 2019	-	-
BIOCARE MEDICAL, INC. CIN: 943275870 , United States, Active	Dec 31, 1999	-	195 (As on Dec 31, 2024)	-

Biocare Medical got acquired by Agilent on Mar 09, 2026 at an acquisition amount of $*****.

Click here to take a look at Biocare Medical's acquisition in detail

Biocare Medical has raised a total funding of $85M over 2 rounds. Its first funding round was on Aug 25, 2017. Its latest funding round was a PE round on Dec 09, 2021 for $*****. 1 investor participated in its latest round. Biocare Medical has 5 institutional investors.

Here is the list of recent funding rounds of Biocare Medical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 09, 2021	2711454	PE	3192497	4314833	8588969	8587512
Aug 25, 2017	9894448	PE	5372791	8942318	Excellere Partners	4631340

Access funding benchmarks and valuations. Sign up today!

View details of Biocare Medical's funding rounds and investors

The founders of Biocare Medical is Roy Paxton Yih.

Here are the details of Biocare Medical's key team members:

Roy Paxton Yih: Co-Founder & CEO of Biocare Medical.
Contact Info: 1 email address

View details of Biocare Medical's Founder profiles and Board Members

Biocare Medical's employee count trend

Biocare Medical has 293 employees as of Jul 26. Here is Biocare Medical's employee count trend over the years:

Employee count trend for Biocare Medical

Uncover Biocare Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biocare Medical include Illumina, Quanterix and BioLife Solutions. Here is the list of Top 10 competitors of Biocare Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
2nd	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Hercules Capital & 15 others	71/100
3rd	BioLife Solutions 1987, Bothell (United States), Public	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
4th	Biocare Medical 1997, Concord (United States), Acquired	Manufacturer of primary antibodies and instruments for immunohistochemistry applications	$85M	GHO Capital Partners, Castle Crow & 3 others	65/100
5th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CPE & 13 others	64/100
6th	Mapi Pharma 2008, Ness Ziona (Israel), Series B	Clinical stage pharmaceutical company developing extended release versions of generic drugs.	$60M	aMoon, Shavit Capital & 3 others	62/100
7th	Siemens Healthineers 1847, Forchheim (Germany), Public	Developer of AI-based medical diagnostic products for the healthcare sector	-	Skyviews Life Science, HHS & 1 others	62/100
8th	Bio-Techne 1981, Minneapolis (United States), Public	Developer of biotech reagents, instruments and clinical diagnostic products	-	HHS	59/100
9th	Abselion 2018, Cambridge (United Kingdom), Series A	Provider of a benchtop instrument for protien research	$12.6M	University of Cambridge, M Ventures & 13 others	59/100
10th	Bio Rad 1952, Hercules (United States), Public	Portfolio of products and services for life science research and clinical diagnostic markets	-	Bellevue Healthcare Trust, HHS & 3 others	58/100